WORK Cash Conversion Cycle from 2010 to 2026

WOK Stock   1.86  0.20  9.71%   
WORK Medical Cash Conversion Cycle yearly trend continues to be quite stable with very little volatility. The value of Cash Conversion Cycle is projected to decrease to 121.49. From the period between 2010 and 2026, WORK Medical, Cash Conversion Cycle regression line of its data series had standard deviation of  107.93 and standard deviation of  107.93. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
228.43
Current Value
121.49
Quarterly Volatility
107.92774865
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check WORK Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WORK Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.2 M, Interest Expense of 410.4 K or Selling General Administrative of 3.2 M, as well as many indicators such as Price To Sales Ratio of 545, Dividend Yield of 0.0 or PTB Ratio of 691. WORK financial statements analysis is a perfect complement when working with WORK Medical Valuation or Volatility modules.
  
Build AI portfolio with WORK Stock
Check out the analysis of WORK Medical Correlation against competitors.

Latest WORK Medical's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of WORK Medical Technology over the last few years. It is WORK Medical's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in WORK Medical's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

WORK Cash Conversion Cycle Regression Statistics

Arithmetic Mean89.53
Geometric Mean43.08
Coefficient Of Variation120.55
Mean Deviation92.10
Median17.65
Standard Deviation107.93
Sample Variance11,648
Range303
R-Value0.75
Mean Square Error5,512
R-Squared0.56
Significance0.0006
Slope15.94
Total Sum of Squares186,374

WORK Cash Conversion Cycle History

2026 121.49
2025 228.43
2023 253.81
2022 321.07
2021 141.44
2020 25.35

About WORK Medical Financial Statements

WORK Medical investors utilize fundamental indicators, such as Cash Conversion Cycle, to predict how WORK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 228.43  121.49 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether WORK Medical Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if WORK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Work Medical Technology Stock. Highlighted below are key reports to facilitate an investment decision about Work Medical Technology Stock:
Check out the analysis of WORK Medical Correlation against competitors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WORK Medical. If investors know WORK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about WORK Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
-2.8 K
Revenue Per Share
78.11
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.09)
The market value of WORK Medical Technology is measured differently than its book value, which is the value of WORK that is recorded on the company's balance sheet. Investors also form their own opinion of WORK Medical's value that differs from its market value or its book value, called intrinsic value, which is WORK Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WORK Medical's market value can be influenced by many factors that don't directly affect WORK Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WORK Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WORK Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WORK Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.